Pneumonia in children
Pediatric pneumonia is the most common respiratory disease in children. It is prone to occur in all seasons. Infants under 3 years old suffer from pneumonia more often in winter and spring. If the treatment is not thorough, it is easy to relapse and cause a variety of serious complications, affecting the child's development. The clinical manifestations of pediatric pneumonia are fever, cough, shortness of breath, dyspnea and fine moist rales in the lungs. There are also patients with no fever but severe cough and wheezing. Pediatric pneumonia has typical symptoms and atypical symptoms, especially neonatal pneumonia. Pneumonia caused by bacteria and viruses is the most common. Currently, pediatric pneumonia can be prevented by vaccines. Common vaccines include Anerbao (Haemophilus influenzae type B conjugate vaccine), 7-valent pneumococcal vaccine, and 23-valent pneumococcal polysaccharide vaccine.
Related Drugs
Ambroxol Hydrochloride Oral Solution
Indication: Suitable for people with thick sputum that is difficult to cough up.
Manufacturer:
Yangzhou NO.3 Pharmacitical Manufacture Co., Ltd.
Prednisolone tablets
Indication: It is used for fever and can also be used to relieve mild to moderate pain, such as headache, muscle pain, and joint pain.
Manufacturer:
Zhejiang Xianju Pharmaceutical Co., Ltd.
Cefepime Hydrochloride for Injection
Indication: This product can be used to treat moderate to severe infections caused by the above-mentioned sensitive bacteria in adults and children aged 2 months to 16 years, including lower respiratory tract infections (pneumonia and bronchitis), simple lower urinary tract infections and complicated urinary tract infections (including pyelonephritis), uncomplicated skin and skin and soft tissue infections, complicated intra-abdominal infections (including peritonitis and biliary tract infections), obstetrics and gynecology infections, sepsis, and empirical treatment of patients with neutropenia and fever. It can also be used for bacterial cerebrospinal meningitis in children. Bacterial culture and drug sensitivity testing should be performed when bacterial infection is suspected, but because cefepime is a broad-spectrum bactericidal agent for Gram-positive and Gram-negative bacteria, cefepime monotherapy can be started before the results of drug sensitivity tests are known. When mixed anaerobic infections are suspected, it is recommended to use other anti-anaerobic drugs in combination.
Manufacturer:
Youcare Pharmaceutical Group Co., Ltd.
Cefepime Hydrochloride for Injection
Indication: This product can be used to treat moderate to severe infections caused by the above-mentioned sensitive bacteria in adults and children aged 2 months to 16 years, including lower respiratory tract infections (pneumonia and bronchitis), simple lower urinary tract infections and complicated urinary tract infections (including pyelonephritis), uncomplicated skin and skin and soft tissue infections, complicated intra-abdominal infections (including peritonitis and biliary tract infections), obstetrics and gynecology infections, sepsis, and empirical treatment of patients with neutropenia and fever. It can also be used for bacterial cerebrospinal meningitis in children. Bacterial culture and drug sensitivity testing should be performed when bacterial infection is suspected, but because cefepime is a broad-spectrum bactericidal agent for Gram-positive and Gram-negative bacteria, cefepime monotherapy can be started before the results of drug sensitivity tests are known. When mixed anaerobic infections are suspected, it is recommended to use other anti-anaerobic drugs in combination.
Manufacturer:
Chengdu Brilliant Pharmaceutical Co., Ltd.
Cefepime Hydrochloride for Injection
Indication: This product can be used to treat moderate to severe infections caused by the above-mentioned sensitive bacteria in adults and children aged 2 months to 16 years, including lower respiratory tract infections (pneumonia and bronchitis), simple lower urinary tract infections and complicated urinary tract infections (including pyelonephritis), uncomplicated skin and skin and soft tissue infections, complicated intra-abdominal infections (including peritonitis and biliary tract infections), obstetrics and gynecology infections, sepsis, and empirical treatment of patients with neutropenia and fever. It can also be used for bacterial cerebrospinal meningitis in children. Bacterial culture and drug sensitivity testing should be performed when bacterial infection is suspected, but because cefepime is a broad-spectrum bactericidal agent for Gram-positive and Gram-negative bacteria, cefepime monotherapy can be started before the results of drug sensitivity tests are known. When mixed anaerobic infections are suspected, it is recommended to use other anti-anaerobic drugs in combination.
Manufacturer:
Zhejiang Yongning Pharmaceutical Co., Ltd.